Welcome to the January 2019 edition of the Baker McKenzie Ukraine Healthcare Newsletter covering December 2018 and January 2019. This is your regular digest of legal developments affecting the life science and healthcare industries in Ukraine.
This edition covers the strategy on implementing the state pharmaceuticals policy until 2025, joint recommendations of the MOH and the MEDT regarding public procurement of pharmaceuticals, postponement of the SI labeling requirement until 2021 and approval of risk criteria to control compliance with pricing regulations. More details on these and other developments affecting the life science and healthcare industries are provided below.
In This Issue
- State pharmaceuticals policy
- Public procurement and reimbursement
- Currency control
- Kazakhstani law amendments